Literature DB >> 6390233

Status of cholinesterase activities in blood in neuropsychiatric disorders.

S I Deutsch, M Campbell.   

Abstract

The availability of easily accessible biochemical trait markers of central cholinergic activity would assist in the identification of homogeneous subgroups of neuropsychiatric patients within specific diagnostic categories. In addition to a refinement of nosology, these measures could also help to design specific treatment interventions. The activities of cholinesterase isoenzymes in blood have been reported to be abnormal in neuropsychiatric disorders with proven or hypothesized abnormalities of central cholinergic transmission. However, the relevance of these peripheral cholinesterase abnormalities to disordered central cholinergic transmission remains uncertain. Future studies examining specific cholinesterase isoenzymes in homogeneous diagnostic groups are needed to determine the potential utility of these measures as peripheral trait markers of central cholinergic activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6390233     DOI: 10.1007/BF00964519

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

Review 1.  Cholinomimetic treatment of neuropsychiatric disorders: a review of recent developments.

Authors:  K L Davis
Journal:  Mt Sinai J Med       Date:  1979 Sep-Oct

2.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 3.  The cholinergic treatment strategy in aging and senile dementia.

Authors:  C A Johns; B S Greenwald; R C Mohs; K L Davis
Journal:  Psychopharmacol Bull       Date:  1983

4.  True and pseudo cholinesterases in depression.

Authors:  R J Mathew; B T Ho; M M Khan; C Perales; M L Weinman; J L Claghorn
Journal:  Am J Psychiatry       Date:  1982-01       Impact factor: 18.112

5.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

6.  Childhood schizophrenia; clinical study on one hundred schizophrenic children.

Authors:  L BENDER
Journal:  Am J Orthopsychiatry       Date:  1947-01

7.  Schizophrenia: a review of diagnostic and biological issues. I. Diagnosis and prognosis.

Authors:  S I Deutsch; K L Davis
Journal:  Hosp Community Psychiatry       Date:  1983-04

8.  Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.

Authors:  K L Davis; P A Berger
Journal:  Biol Psychiatry       Date:  1978-02       Impact factor: 13.382

9.  Cholinesterase enzymes in the blood of patients with Alzheimer's disease.

Authors:  R C Smith; B T Ho; L Hsu; G Vroulis; J Claghorn; J Schoolar
Journal:  Life Sci       Date:  1982-02-07       Impact factor: 5.037

10.  Changes in brain cholinesterases in senile dementia of Alzheimer type.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Jul-Aug       Impact factor: 8.090

View more
  1 in total

1.  The influence of catecholamines on pseudocholinesterase enzymatic activity. Results of a laboratory investigation.

Authors:  Thomas Ledowski; Michael J Paech; Michael Clarke; Stephan A Schug
Journal:  J Clin Monit Comput       Date:  2006-09-05       Impact factor: 2.502

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.